Combined anti-inflammatory and neuroprotective treatments have the potential to impact disease phenotypes in Cln3 -/- mice

Combined anti-inflammatory and neuroprotective treatments have the potential to impact disease phenotypes in Cln3 -/- mice

Batten disease, or juvenile NCL, is a fatal neurodegenerative disorder that occurs due to mutations in the CLN3 gene. Because the function of CLN3 remains unclear, experimental therapies for JNCL have largely concentrated upon the targeting of downstream pathomechanisms. Neuron loss is preceded by l...

Bibliografiset tiedot
Päätekijät:	Tarczyluk-Wells, M, Salzlechner, C, Najafi, A, Lim, M, Smith, D, Platt, F, Williams, B, Cooper, J
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2019

Samankaltaisia teoksia

Combined Anti-inflammatory and Neuroprotective Treatments Have the Potential to Impact Disease Phenotypes in Cln3−/− Mice
Tekijä: Marta A. Tarczyluk-Wells, et al.
Julkaistu: (2019-09-01)

Phenotypic variant of CLN3 mutation
Tekijä: Avinash Honasoge, et al.
Julkaistu: (2022-09-01)

Repurposing of tamoxifen ameliorates CLN3 and CLN7 disease phenotype
Tekijä: Chiara Soldati, et al.
Julkaistu: (2021-08-01)

Exacerbated neuronal ceroid lipofuscinosis phenotype in Cln1/5 double-knockout mice
Tekijä: Tea Blom, et al.
Julkaistu: (2013-03-01)

Invited editorial in regards to phenotypic variant of CLN3 mutation
Tekijä: Avinash Honasoge, et al.
Julkaistu: (2023-03-01)

Anti-inflammatory treatment with acetylsalicylate or rofecoxib is not neuroprotective in Huntington's disease transgenic mice
Tekijä: Fran Norflus, et al.
Julkaistu: (2004-11-01)

Beige adipocytes mediate the neuroprotective and anti-inflammatory effects of subcutaneous fat in obese mice
Tekijä: De-Huang Guo, et al.
Julkaistu: (2021-07-01)

CLN6‐related continuum phenotype caused by aberrant splicing
Tekijä: Federica Invernizzi, et al.
Julkaistu: (2025-02-01)

Brain gene expression profiles of <it>Cln1 </it>and <it>Cln5 </it>deficient mice unravels common molecular pathways underlying neuronal degeneration in NCL diseases
Tekijä: Gentile Massimiliano, et al.
Julkaistu: (2008-03-01)

An altered transcriptome underlies cln5-deficiency phenotypes in Dictyostelium discoideum
Tekijä: William D. Kim, et al.
Julkaistu: (2022-11-01)

Data on characterizing the gene expression patterns of neuronal ceroid lipofuscinosis genes: CLN1, CLN2, CLN3, CLN5 and their association to interneuron and neurotransmission markers: Parvalbumin and Somatostatin
Tekijä: Helena M. Minye, et al.
Julkaistu: (2016-09-01)

Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype
Tekijä: Moehle Christoph, et al.
Julkaistu: (2010-01-01)

Phytochemicals from <i>Passiflora coriacea</i> Juss. Have Anti-Inflammatory and Neuroprotective Effects in Mouse Models
Tekijä: Samir Castolo-Sanchez, et al.
Julkaistu: (2024-11-01)

Correction: Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype
Tekijä: Dirscherl Konstantin, et al.
Julkaistu: (2012-06-01)

Mechanism of Siponimod: Anti-Inflammatory and Neuroprotective Mode of Action
Tekijä: Newshan Behrangi, et al.
Julkaistu: (2019-01-01)

A novel porcine model of CLN3 Batten disease recapitulates clinical phenotypes
Tekijä: Vicki J. Swier, et al.
Julkaistu: (2023-08-01)

Targeting autophagy impairment improves the phenotype of a novel CLN8 zebrafish model
Tekijä: Maria Marchese, et al.
Julkaistu: (2024-07-01)

Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheep
Tekijä: Hemanth R. Nelvagal, et al.
Julkaistu: (2022-10-01)

Cln5-deficiency in mice leads to microglial activation, defective myelination and changes in lipid metabolism
Tekijä: Mia-Lisa Schmiedt, et al.
Julkaistu: (2012-04-01)

Gene expression profiling in brain of mice exposed to the marine neurotoxin ciguatoxin reveals an acute anti-inflammatory, neuroprotective response
Tekijä: Ryan James C, et al.
Julkaistu: (2010-08-01)

Neuroprotective Effect of Catalpol via Anti-Oxidative, Anti-Inflammatory, and Anti-Apoptotic Mechanisms
Tekijä: Chunjing Yang, et al.
Julkaistu: (2020-05-01)

Neuroprotective and Anti-inflammatory Effects of Pioglitazone on Traumatic Brain Injury
Tekijä: Mohammad Yassin Zamanian, et al.
Julkaistu: (2022-01-01)

Structural Requirements for the Neuroprotective and Anti-Inflammatory Activities of the Flavanone Sterubin
Tekijä: Zhibin Liang, et al.
Julkaistu: (2022-11-01)

Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann–Pick disease type C1 mice
Tekijä: Ian M. Williams, et al.
Julkaistu: (2014-07-01)

Electroretinography data from ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinoses
Tekijä: Katharina N. Russell, et al.
Julkaistu: (2021-08-01)

Glycerophosphoinositol is Elevated in Blood Samples From pigs, Mice, and CLN3-Affected Individuals
Tekijä: Jon J Brudvig, et al.
Julkaistu: (2022-06-01)

TRPML1 activation ameliorates lysosomal phenotypes in CLN3 deficient retinal pigment epithelial cells
Tekijä: D. Wünkhaus, et al.
Julkaistu: (2024-07-01)

Combined anti-inflammatory and anti-AGE drug treatments have a protective effect on intervertebral discs in mice with diabetes.
Tekijä: Svenja Illien-Junger, et al.
Julkaistu: (2013-01-01)

in vivo localization of the neuronal ceroid lipofuscinosis proteins, CLN3 and CLN7, at endogenous expression levels
Tekijä: Alamin Mohammed, et al.
Julkaistu: (2017-07-01)

Loss of Cln5 leads to altered Gad1 expression and deficits in interneuron development in mice
Tekijä: Singh, Y, et al.
Julkaistu: (2019)

Sex- and region-biased depletion of microglia/macrophages attenuates CLN1 disease in mice
Tekijä: Kristina Berve, et al.
Julkaistu: (2020-10-01)

An anti-inflammatory and neuroprotective biomimetic nanoplatform for repairing spinal cord injury
Tekijä: Xiang Gao, et al.
Julkaistu: (2022-12-01)

The Antioxidant, Anti-Inflammatory, and Neuroprotective Properties of the Synthetic Chalcone Derivative AN07
Tekijä: Yih-Fung Chen, et al.
Julkaistu: (2020-06-01)

Characterisation of early changes in ovine CLN5 and CLN6 Batten disease neural cultures for the rapid screening of therapeutics
Tekijä: Hannah L Best, et al.
Julkaistu: (2017-04-01)

An Unusual Presentation of Neuronal Ceroid Lipofuscinosis With CLN6 Mutation
Tekijä: Shahin Koohmanaee, et al.
Julkaistu: (2023-01-01)

Sex-split analysis of pathology and motor-behavioral outcomes in a mouse model of CLN8-Batten disease reveals an increased disease burden and trajectory in female Cln8 mnd mice
Tekijä: Andrew D. Holmes, et al.
Julkaistu: (2022-11-01)

Physiotherapy for Children with CLN2 Disease
Tekijä: Ina von Löbbecke
Julkaistu: (2019-11-01)

Progressive thalamocortical neuron loss in Cln5 deficient mice: Distinct effects in Finnish variant late infantile NCL
Tekijä: Carina von Schantz, et al.
Julkaistu: (2009-05-01)

Annexin A1: a central player in the anti-inflammatory and neuroprotective role of microglia.
Tekijä: McArthur, S, et al.
Julkaistu: (2010)

Gene disruption of Mfsd8 in mice provides the first animal model for CLN7 disease
Tekijä: Markus Damme, et al.
Julkaistu: (2014-05-01)